# FUROSEMIDE
> **ANDA216860** · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2022-12-16
## Drug
- **FDA Application Number:** ANDA216860
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FUROSEMIDE
- **Generic name:** FUROSEMIDE
- **Active ingredients:** FUROSEMIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** MANKIND PHARMA
- **Manufacturer:** Lifestar Pharma LLC
- **First approval:** 2022-12-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216860)
---
*AI Analytics · CC0 1.0*